Use of ADHD medication in UK more than tripled in 13 years, study finds
AI Summary
A recent study published in The Lancet Regional Health – Europe found a significant increase in ADHD medication use across several European countries between 2010 and 2023. Researchers, led by the University of Oxford, analyzed electronic health records from Belgium, Germany, the Netherlands, Spain, and the UK. The UK experienced the highest relative increase, more than tripling from 0.12% to 0.39%. Adult use, particularly among women over 25, saw a substantial rise in all countries, suggesting increased awareness and diagnosis of adult ADHD. While methylphenidate remained the most common medication, the study also revealed a lower rate of medication use compared to the estimated prevalence of ADHD, highlighting potential unmet treatment needs and the importance of healthcare systems planning for increased demand.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories